Organization
Edouard Herriot Hospital
2 abstracts
Abstract
177Lu-edotreotide versus everolimus in patients with advanced neuroendocrine tumors of lung or thymic origin: The phase 3 randomized LEVEL, GETNE-T2217 trial.Org: Imas12, UCM, Hospital Universitario Central de Asturias, ISPA, University Clinical Hospital of Santiago de Compostela,
Abstract
Comparison of generic and specific anxiety in patients treated with apalutamide plus active surveillance vs active surveillance alone for low and intermediate risk prostate cancer.Org: Institut Paoli-Calmettes, Marseille, France, Aix-Marseille Universite, CRCM, Inserm U1308- CAPTuR- Control of cell Activation in Tumor Progression and Therapeutic Resistance, IRD,